Dextran API Manufacturers

Looking for Dextran API 9004-54-0?

Description:

Here you will find a list of producers, manufacturers and distributors of Dextran. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Dextran 

Cas Number:

9004-54-0 

DrugBank number:

DB09255 

Unique Ingredient Identifier:

EW7Q6SVD0D

Dextran is a type of Blood and plasma products

Blood and plasma products are a vital subcategory within the pharmaceutical API (Active Pharmaceutical Ingredients) industry. These products play a crucial role in medical treatments, especially in situations where patients require transfusions or therapies related to blood disorders.

Blood and plasma products are derived from human blood or plasma, which undergoes a rigorous process of collection, screening, and processing to ensure safety and efficacy. The primary purpose of these products is to supplement or replace deficient components within a patient's blood, such as red blood cells, platelets, or clotting factors.

One of the key blood and plasma products is fresh frozen plasma (FFP). FFP contains a broad spectrum of clotting factors and proteins necessary for effective blood clotting. It is often administered to patients with coagulation disorders or those who have experienced significant blood loss due to trauma or surgery.

Another important product is albumin, a protein found in plasma. Albumin plays a crucial role in maintaining blood volume and regulating osmotic pressure. It is used in conditions such as hypovolemia, hypoalbuminemia, and burns.

Immunoglobulins, also known as antibodies, are another vital component of blood and plasma products. These antibodies are isolated and purified from human plasma and are utilized in various therapeutic applications, including immune deficiencies, autoimmune disorders, and certain infectious diseases.

The production and distribution of blood and plasma products require strict adherence to regulatory guidelines and quality standards to ensure patient safety. These products are subject to extensive testing for pathogens, compatibility, and sterility to minimize the risk of adverse reactions or infections.

In conclusion, blood and plasma products form an integral part of the pharmaceutical API subcategory, providing essential components for treating various medical conditions. Their production, processing, and distribution involve rigorous quality control measures to ensure patient well-being and optimal therapeutic outcomes.

Dextran (Blood and plasma products), classified under Blood Products

Blood products are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in various medical treatments. These products are derived from human blood or obtained through biotechnology processes. Blood products are rich in essential components like plasma proteins, coagulation factors, and immunoglobulins, which are fundamental for various therapeutic applications.

One key blood product API is plasma-derived products. Plasma is separated from whole blood and processed to extract specific proteins, such as albumin, immunoglobulins, and clotting factors. These APIs are widely used to treat conditions like immunodeficiency disorders, hemophilia, and autoimmune diseases. They provide essential therapeutic support, enhancing patients' immune response and addressing coagulation deficiencies.

Another significant blood product API category comprises recombinant blood factors. Through genetic engineering techniques, these APIs are produced in laboratory settings. Recombinant factors, such as factor VIII and factor IX, are essential for treating hemophilia patients who lack these specific clotting factors.

Blood product APIs are manufactured under strict regulatory guidelines to ensure safety and efficacy. These products undergo rigorous testing for viral and bacterial contamination and are subjected to stringent quality control measures to guarantee their purity and potency.

In conclusion, blood product APIs are critical components in the pharmaceutical industry, providing essential therapeutic support for various medical conditions. Plasma-derived and recombinant blood factors are integral to the treatment of immunodeficiency disorders, hemophilia, and autoimmune diseases. These APIs are manufactured following stringent quality standards to ensure their safety and effectiveness for patient care.

• Arshine Pharmaceutical Co., Limited from China, product country of origin China
• Chr. Olesen Group from Denmark, product country of origin Unknown
• Aurora Industry Co., Ltd from China, product country of origin China
• Sichuan Kelun Pharmaceutical Co Ltd from China, product country of origin China
• Guangxi Guanghong Pharmaceutical Co Ltd from China, product country of origin China
• Pharmacosmos A/S from Denmark, product country of origin Denmark

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.